M42 - Middle East News 247
January 12, 2025
Home Posts tagged M42 (Page 3)

M42

NEWS DESK

M42 launches proteomics grant competition

M42, a global tech-enabled health powerhouse, has partnered with the US-based biotechnology company SomaLogic to launch a proteomics grant competition, a first in the region, aimed at inspiring researchers to harness the vast potential of proteomics research. Proteomics, the study of proteomes, the complete set of proteins produced in an organism, plays a pivotal role […]
NEWS DESK

M42 and Broad Institute work together with Microsoft

M42 — a first-of-its-kind health powerhouse committed to reshaping the sustainable future of health with technology as a key enabler — and Broad Institute of MIT and Harvard will work with Microsoft and the International Center for Genetic Disease. The group will leverage the Terra platform to explore scenarios for precision health discovery and delivery, […]
NEWS DESK

Lighting the Path to Awareness

In a symbolic gesture of solidarity and commitment to global health and diabetes awareness, M42 partners illuminated their facades in blue for World Diabetes Day. Celebrated on the 14th of November, the occasion saw prominent landmarks, including Mubadala Tower, Cleveland Clinic Abu Dhabi, Imperial College London Diabetes Centre, Amana Healthcare, Danat Al Emarat Women
NEWS DESK

M42: Abu Dhabi’s global health-tech innovator takes on sustainability challenges at COP28

M42, a first-of-its-kind globaltech-enabled healthcare company headquartered in Abu Dhabi, is set to have presence at the 28th session of the Conference of Parties (COP28) as the summit’s Principal Health Partner. M42, which integrates G42 Healthcare’s unique medical and data-centric technologies with Mubadala Health’s world-class provision of care, will promote dialogue
NEWS DESK

M42’s Healthpoint launches state-of-the-art catheterization

Healthpoint, an M42 company, is launching a new, state-of-the-art catheterization laboratory (cath lab) at its hospital in Zayed Sports City, Abu Dhabi, to treat a range of vascular conditions. It has introduced several minimally invasive vascular procedures at the new laboratory beneficial for patients with blocked arteries, patients needing vascular access for dialysis,
NEWS DESK

Amana Healthcare Earns Third JCI Accreditation

Amana Healthcare, an M42 company, is proud to announce that it has been awarded the Joint Commission International (JCI) accreditation for three consecutive years. Over the course of five days, an official surveyor conducted a thorough assessment of Amana Healthcare’s long-term care facilities to grant the accreditation once more. The first time one of Amana […]